Carregant...
A novel nasal powder formulation of glucagon: toxicology studies in animal models
BACKGROUND: Glucagon nasal powder (GNP), a novel intranasal formulation of glucagon being developed to treat insulin-induced severe hypoglycemia, contains synthetic glucagon (10 % w/w), beta-cyclodextrin, and dodecylphosphocholine. The safety of this formulation was evaluated in four studies in anim...
Guardat en:
| Publicat a: | BMC Pharmacol Toxicol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4621930/ https://ncbi.nlm.nih.gov/pubmed/26502880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-015-0026-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|